Literature DB >> 17536076

Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.

Sergio Valdés1, Patricia Botas, Elias Delgado, Francisco Alvarez, Francisco Diaz Cadórniga.   

Abstract

OBJECTIVE: The aim of this study was to define the incidence of type 2 diabetes in a low-risk Caucasian population in northern Spain and its association with various risk factors. RESEARCH DESIGN AND METHODS: The Asturias Study is a prospective, population-based survey of diabetes and cardiovascular risk factors. The baseline examination was carried out during 1998-1999 when 1,034 individuals, aged 30-75 years, were randomly selected to determine the prevalence of type 2 diabetes and pre-diabetes in the Principality of Asturias (northern Spain). In 2004-2005, these same subjects were invited for a follow-up examination; 700 participated. This study includes only those individuals who did not have diabetes at baseline. We used the World Health Organization 1999 criteria to classify glucose metabolism at both baseline and follow-up.
RESULTS: The incidence of diabetes adjusted for the age and sex structure of Asturias was 10.8 cases/1,000 person-years (95% CI 8.1-14.8). The incidence rates were 5 cases/1,000 person-years in individuals with normoglycemia, 21 cases/1,000 person-years in individuals with isolated impaired glucose tolerance (IGT), 34.7 cases/1,000 person-years in individuals with isolated impaired fasting glucose (IFG), and 95.2 cases/1,000 person-years in individuals with combined IFG-IGT. Stepwise multiple logistic regression analysis showed that, together with fasting plasma glucose (FPG) and 2-h plasma glucose, which were the strongest predictors of diabetes, triglycerides and BMI were also independently associated with progression to diabetes.
CONCLUSIONS: In this 6-year prospective population-based study, we found an incidence of type 2 diabetes of 10.8 cases/1,000 person-years. Both FPG and 2-h plasma glucose were strongly predictive of diabetes, and their effect was additive.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17536076     DOI: 10.2337/dc06-2461

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  37 in total

1.  Association between glycemic index, glycemic load, and fructose with insulin resistance: the CDC of the Canary Islands study.

Authors:  Santiago Domínguez Coello; Antonio Cabrera de León; María C Rodríguez Pérez; Carlos Borges Álamo; Lourdes Carrillo Fernández; Delia Almeida González; Jezabel García Yanes; Ana González Hernández; Buenaventura Brito Díaz; Armando Aguirre-Jaime
Journal:  Eur J Nutr       Date:  2010-04-25       Impact factor: 5.614

2.  Treatment prevalence and incidence of schizophrenia in Quebec using a population health services perspective: different algorithms, different estimates.

Authors:  Alain Vanasse; Josiane Courteau; Marie-Josée Fleury; Jean-Pierre Grégoire; Alain Lesage; Jocelyne Moisan
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-29       Impact factor: 4.328

3.  The relative associations of β-cell function and insulin sensitivity with glycemic status and incident glycemic progression in migrant Asian Indians in the United States: the MASALA study.

Authors:  Unjali P Gujral; K M Venkat Narayan; Steven E Kahn; Alka M Kanaya
Journal:  J Diabetes Complications       Date:  2013-10-11       Impact factor: 2.852

4.  Lifetime risk and projected population prevalence of diabetes.

Authors:  D J Magliano; J E Shaw; S M Shortreed; W J Nusselder; D Liew; E L M Barr; P Z Zimmet; A Peeters
Journal:  Diabetologia       Date:  2008-09-23       Impact factor: 10.122

5.  General effect on high-risk persons when general practitioners are trained in intensive treatment of type 2 diabetes.

Authors:  Signe S Rasmussen; Charlotte Glümer; Annelli Sandbaek; Torsten Lauritzen; Knut Borch-Johnsen
Journal:  Scand J Prim Health Care       Date:  2008       Impact factor: 2.581

6.  Targeting the association of calgranulin B (S100A9) with insulin resistance and type 2 diabetes.

Authors:  Francisco J Ortega; Josep M Mercader; José M Moreno-Navarrete; Mónica Sabater; Neus Pueyo; Sergio Valdés; Bartomeu Ruiz; Elodie Luche; Matteo Serino; Deborah Naon; Wifredo Ricart; Patricia Botas; Elias Delgado; Remy Burcelin; Gema Frühbeck; Fatima Bosch; Gertrude Mingrone; Antonio Zorzano; José M Fernández-Real
Journal:  J Mol Med (Berl)       Date:  2012-12-04       Impact factor: 4.599

7.  Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark.

Authors:  S S Rasmussen; C Glümer; A Sandbaek; T Lauritzen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2007-12-05       Impact factor: 10.122

8.  Optimal strategy to identify incidence of diagnostic of diabetes using administrative data.

Authors:  Shabnam Asghari; Josiane Courteau; André C Carpentier; Alain Vanasse
Journal:  BMC Med Res Methodol       Date:  2009-08-28       Impact factor: 4.615

9.  Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran.

Authors:  Hadi Harati; Farzad Hadaegh; Navid Saadat; Fereidoun Azizi
Journal:  BMC Public Health       Date:  2009-06-16       Impact factor: 3.295

10.  Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity.

Authors:  José Manuel Fernández-Real; Sergio Valdés; Melania Manco; Berta Chico; Patricia Botas; Arantza Campo; Roser Casamitjana; Elías Delgado; Javier Salvador; Gema Fruhbeck; Geltrude Mingrone; Wifredo Ricart
Journal:  Diabetes Care       Date:  2010-01-19       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.